Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:23 PM ET 8-K/A
Divestiture Boston Omaha Corp BOC

Boston Omaha Divestiture to CopperPoint Insurance Company for $84.3M

Boston Omaha Corporation completed the sale of its General Indemnity Group (GIG) business unit to CopperPoint Insurance Company for a gross purchase price of approximately $84.3 million. As part of the transaction, Boston Omaha received $75.3 million in net cash proceeds at closing and the return of 2,673,831 shares of Sky Harbour Class A common stock previously held by the subsidiary.

Value
$84.3M
Counterparty
CopperPoint Insurance Company
4:21 PM ET 8-K
Capital Raise Cadiz Inc CDZI

Cadiz Capital Raise of $21M

Cadiz Inc. entered into a placement agent agreement for a registered direct offering of 5,000,000 shares of common stock at $4.20 per share, raising $21 million in gross proceeds. The company intends to use the net proceeds for general corporate purposes and to advance the development and construction of the Mojave Groundwater Bank Project.

Value
$21M
Counterparty
Roth Capital Partners, LLC
4:20 PM ET 8-K
Clinical Trial Data CervoMed Inc. CRVO

CervoMed Clinical Trial Data

CervoMed announced the publication of peer-reviewed results from its Phase 2b RewinD-LB clinical trial of neflamapimod in dementia with Lewy bodies (DLB). While the trial did not meet its primary endpoint in the full population, data showed a statistically significant increase in right basal forebrain volume and greater clinical benefit in patients without Alzheimer’s disease co-pathology.

4:16 PM ET 8-K
Contract Win Workhorse Group Inc. WKHS

Workhorse Group Wins $10M Contract from Rhaelm Holdings Limited

Workhorse Group entered into a $10 million Manufacturing Spec Unit Purchase Agreement with Rhaelm Holdings Limited to build a full-scale TerraPod modular data center manufacturing spec unit in Indiana. The parties also signed a non-binding letter of intent for a future supply agreement targeting an initial order of 150 TerraPod systems by the end of 2026.

Value
$10M
Counterparty
Rhaelm Holdings Limited
Term
through Dec 2026

“Our partnership announcement with RHAELM goes beyond acting as a launchpad for our TerraPod product; we believe it’s the beginning of an era of mass production of the systems that will enable rapid deployment of cost-effective, secure and highly distributed AI compute capabilities.”

Scott Griffith, Chief Executive Officer of Workhorse
4:16 PM ET 8-K
Divestiture Sanara MedTech Inc. SMTI

Sanara MedTech Divestiture for $2M

Sanara MedTech Inc. sold all assets of its wholly owned subsidiary, Tissue Health Plus, LLC (THP), to an unrelated third party. The transaction included THP's business software products and intellectual property for approximately $2.0 million plus certain earnout rights.

Value
$2M
4:16 PM ET 8-K
Nasdaq/NYSE Compliance Notice CID Holdco, Inc. DAIC

CID Holdco Nasdaq/NYSE Compliance Notice

CID HoldCo, Inc. (Dot Ai) received a favorable decision from the Nasdaq Hearings Panel allowing the company to continue its listing on The Nasdaq Stock Market. The decision is subject to the company transferring its listing to The Nasdaq Capital Market by November 2, 2026, following the company's successful acquisition of Envoy Technologies and regained compliance with shareholders' equity requirements.

Counterparty
Nasdaq
4:14 PM ET 8-K
Divestiture Unifi Inc UFI

Unifi Divestiture to Enovum Data Centers Corp. for $60M

Unifi, Inc. completed the sale of non-strategic real estate assets in Yadkin County, North Carolina, to Enovum for $60 million in cash. The company used the net proceeds to fully repay its $55.5 million term loan balance and a portion of its revolving credit facility, significantly strengthening its balance sheet.

Value
$60M
Counterparty
Enovum Data Centers Corp.
4:08 PM ET 8-K
M&A Deal Mineralys Therapeutics, Inc. MLYS

Mineralys Therapeutics M&A Deal with Tanabe Pharma Corporation

Mineralys Therapeutics entered into a Termination Agreement and Payment Obligation Agreement with Tanabe Pharma Corporation to acquire full ownership of the intellectual property for lorundrostat. The agreements terminate the existing license and assign the patents and know-how directly to Mineralys, while maintaining existing commercial milestone obligations of up to $265 million. This transition from licensee to owner removes potential change-of-control payment triggers and consolidates the company's control over its lead drug candidate.

Counterparty
Tanabe Pharma Corporation
4:07 PM ET 8-K/A
M&A Deal Varex Imaging Corp VREX

Varex Imaging M&A Deal with Teledyne Technologies Incorporated

Varex Imaging Corporation stockholders have approved the definitive merger agreement for the company to be acquired by Teledyne Technologies Incorporated. Approximately 77% of outstanding shares were represented at the special meeting, with the vast majority voting in favor of the transaction. The deal remains subject to various closing conditions as Varex will become a wholly owned subsidiary of Teledyne upon completion.

Counterparty
Teledyne Technologies Incorporated
4:07 PM ET 8-K
Divestiture XWELL, Inc. XWEL

XWELL Divestiture to Express Wellness Group, LLC

XWELL stockholders approved the sale of the company's equity interests in XpresSpa Holdings, LLC and XpresTest, Inc. to Express Wellness Group, LLC. The approval was obtained at a special meeting held on October 28, 2026, where shareholders also approved an increase in the number of shares reserved for the company's 2020 equity incentive plan.

Counterparty
Express Wellness Group, LLC
4:06 PM ET 8-K/A
Divestiture Faraday Future Intelligent Electric Inc. FFAI

Faraday Future Intelligent Electric Divestiture to FF EAI Robotics Ecosystem Inc. for $10M

Faraday Future completed the disposition and reorganization of its robotics business into FF EAI Robotics Ecosystem Inc. (FFR) on October 23, 2026. In connection with the transaction, FFR secured a $10.0 million PIPE financing from two investors, while remaining a consolidated subsidiary of Faraday Future.

Value
$10M
Counterparty
FF EAI Robotics Ecosystem Inc.
4:06 PM ET 8-K
M&A Deal Marketaxess Holdings Inc MKTX

Marketaxess Holdings M&A Deal with Intercontinental Exchange, Inc.

MarketAxess stockholders approved the company's acquisition by Intercontinental Exchange, Inc. (ICE) at a special meeting held on October 29, 2026. The transaction, which will result in MarketAxess becoming a wholly owned subsidiary of ICE, remains subject to regulatory approvals and is expected to close in the first quarter of 2027.

Counterparty
Intercontinental Exchange, Inc.
4:05 PM ET 8-K
M&A Deal Outdoor Specialty Products, Inc. ODRS

Outdoor Specialty Products Signs $1.5M M&A Deal with Quantum Qualified Opportunity Fund, LLC

Outdoor Specialty Products, Inc. entered into a Stock Purchase Agreement with Quantum Qualified Opportunity Fund, LLC, which will acquire a controlling interest in the company. Quantum will purchase 24,402,042 shares of common stock for $1.5 million in cash, while existing principal stockholders will exchange 4,000,000 common shares for newly authorized Series A Preferred Stock.

Value
$1.5M
Counterparty
Quantum Qualified Opportunity Fund, LLC
4:02 PM ET 8-K
Capital Raise SL Investment Fund II LLC

SL Investment Fund II Capital Raise of $29.7M

SL Investment Fund II LLC completed a capital drawdown from its unitholders, selling approximately 1.52 million common units for total proceeds of $29.7 million. The sale was conducted under existing subscription agreements where investors fund capital commitments on an as-needed basis. The transaction closed on October 27, 2026, and was conducted as a private placement exempt from registration.

Value
$29.7M
4:02 PM ET 8-K
M&A Deal Foxo Technologies Inc. FOXO

Foxo Technologies Signs $3.25M M&A Deal with Ludwig Enterprises, Inc.

FOXO Technologies entered into definitive agreements to acquire 5,000,000 shares of Ludwig Enterprises preferred stock, representing approximately 71.43% of the outstanding preferred stock and providing voting control. The total consideration includes $2.75 million in new Series F Preferred Stock and $0.5 million in cash to acquire preferred shares and outstanding notes. Ludwig is a genomic technology company developing mRNA biomarkers for detecting inflammation-related chronic diseases.

Value
$3.25M
Counterparty
Ludwig Enterprises, Inc.
2:49 PM ET 8-K
Capital Raise VistaOne, L.P.

VistaOne Capital Raise of $29.5M

VistaOne, L.P. sold unregistered limited partnership units for aggregate consideration of approximately $29.1 million to third-party investors as part of its continuous private offering. Additionally, the Fund sold Class E Units to employees of Vista Equity Partners Management, LLC for $405,000, bringing the total raised to approximately $29.5 million.

Value
$29.5M
2:01 PM ET 8-K
Capital Raise Adams Street Credit Solutions Fund

Adams Street Credit Solutions Fund Capital Raise of $694K

Adams Street Credit Solutions Fund sold 34,563.475 Class I common shares for approximately $0.69 million in its October 2026 monthly closing. The shares were issued at a price of $20.08 per share, representing the fund's net asset value as of September 30, 2026.

Value
$694K
1:29 PM ET 8-K
Capital Raise Bbcms Mortgage Trust 2026-5C43

Bbcms Mortgage Trust 2026-5C43 Capital Raise

BBCMS Mortgage Trust 2026-5C43 completed the issuance of Commercial Mortgage Pass-Through Certificates, Series 2026-5C43. The certificates represent beneficial ownership in a trust consisting of 43 commercial, multifamily, and manufactured housing community mortgage loans. The public and private certificates were sold to a group of underwriters and initial purchasers including Barclays, Deutsche Bank, and Citigroup.

Counterparty
Barclays Capital Inc.
12:34 PM ET
Earnings Call Cactus, Inc. WHD ▶ Call

Cactus Earnings Call: Key Takeaways

Cactus delivered a resilient quarter with spoolable technology revenue growing 20% sequentially, offsetting pressure control declines, while announcing a major $100 million Middle East manufacturing expansion.

Call
Oct 29, 2026, 10:00 AM ET
9:25 AM ET 8-K
Partnership Celularity Inc CELU

Celularity Partnership with Vesalius Longevity Labs Inc.

Celularity entered into an exclusive manufacturing and commercial collaboration with Vesalius Longevity Labs to establish a U.S.-based manufacturing and supply platform for Peptual-branded peptide active pharmaceutical ingredients (APIs). Celularity will utilize its Florham Park, New Jersey facility to perform downstream purification, processing, and analytical testing of bulk peptide material under cGMP standards.

Counterparty
Vesalius Longevity Labs Inc.
9:24 AM ET 8-K
M&A Deal ADT Inc. ADT

ADT Signs $15.3B M&A Deal with Thrive Holdings

ADT Inc. has entered into a definitive agreement to be acquired by Thrive Holdings in an all-cash transaction valued at approximately $15.3 billion in enterprise value. ADT stockholders will receive $10.00 per share, representing a 45.6% premium to the unaffected closing price, and the company will become privately held upon completion.

Value
$15.3B
Counterparty
Thrive Holdings

“ADT is pleased to enter into this transaction, which recognizes the value built by our more than 12,000 employees and delivers an attractive cash premium to our stockholders. Our leadership in security is based on a legacy of trust, longstanding customer relationships and the dedication of our employees. With Thrive Holdings’ long-term capital and technology expertise, ADT will gain new opportunities to accelerate innovation, enhance the customer experience and bring greater peace of mind to even more homes and businesses.”

Jim DeVries, Chairman, President and Chief Executive Officer of ADT
9:13 AM ET 8-K
M&A Deal Inflection Point Acquisition Corp. VI IPFX

Inflection Point Acquisition Corp. VI Signs $300M M&A Deal with Quantum Space, LLC

Inflection Point Acquisition Corp. VI announced that the SEC has declared effective its Registration Statement on Form S-4 for its previously announced business combination with Quantum Space, LLC. The deal includes approximately $300 million in committed PIPE financing and a shareholder vote is scheduled for November 20, 2026. Upon closing, the combined company will be renamed Quantum Space, Inc. and is expected to trade on the NYSE under the ticker QSPC.

Value
$300M
Counterparty
Quantum Space, LLC
9:12 AM ET 8-K
M&A Deal Varex Imaging Corp VREX

Varex Imaging M&A Deal with Teledyne Technologies Incorporated

Varex Imaging Corporation stockholders approved the company's acquisition by Teledyne Technologies Incorporated at a special meeting held on October 28, 2026. Approximately 77% of outstanding shares were represented, with the merger agreement adoption receiving overwhelming support. The transaction remains subject to regulatory approvals, including Hart-Scott-Rodino clearance and foreign investment laws.

Counterparty
Teledyne Technologies Incorporated
9:04 AM ET 8-K
Divestiture Perrigo Co plc PRGO

Perrigo Co Divestiture to MeridianMade for $175M

Perrigo Company plc has entered into a definitive agreement to divest its Infant Formula business to MeridianMade for up to $175 million, consisting of $40 million in cash and $135 million in performance-based milestones. The deal advances Perrigo's 'Three-S' plan to streamline its portfolio and focus on core consumer self-care products. The transaction is expected to close in the first half of 2027, subject to regulatory approvals.

Value
$175M
Counterparty
MeridianMade
8:53 AM ET 8-K
Product Launch Canton Strategic Holdings, Inc. CNTN

Canton Strategic Holdings Product Launch

Canton Strategic Holdings announced an agreement with TSV LLC to make its common stock available as the first tokenized U.S. equity for 24/7 trading on the Canton Network. The company has engaged Fairmint, an SEC-registered onchain transfer agent, to issue the tokenized shares, which are expected to begin trading as early as November 2, 2026.

Counterparty
TSV LLC
8:47 AM ET 8-K
Regulatory Approval Processa Pharmaceuticals, Inc. PCSA

Processa Pharmaceuticals Regulatory Approval

Processa Pharmaceuticals announced that the FDA has cleared its Investigational New Drug (IND) application for VT-7208, allowing the company to initiate a Phase 2 study in patients with chronic spontaneous urticaria. The company also appointed Dr. Sheila Gujrathi as Executive Chair and entered into a research collaboration with Generian Pharmaceuticals to expand its pipeline.

8:45 AM ET 8-K
Divestiture Eightco Holdings Inc. ORBS

Eightco Holdings Divestiture for $20M

Eightco Holdings' subsidiary, AI Innovation Capital LLC, completed the sale of a portion of its indirect interest in OpenAI Group, PBC for $20 million in cash. The monetization was executed at a price approximately 40% above the initial purchase price, and the company intends to use the proceeds to accelerate its existing $125 million share repurchase program.

Value
$20M
8:32 AM ET 8-K
M&A Deal Maplebear Inc. CART

Maplebear Signs $17B M&A Deal with DoorDash, Inc.

Maplebear Inc. (Instacart) has entered into a definitive agreement to be acquired by DoorDash, Inc. for $65.00 per share, representing an equity value of approximately $17 billion. The transaction consideration will be at least 75% cash, with Instacart stockholders able to elect cash, DoorDash stock, or a combination of both, subject to proration.

Value
$17B
Counterparty
DoorDash, Inc.
8:30 AM ET 8-K
Capacity Expansion Centrus Energy Corp LEU

Centrus Energy Capacity Expansion

Centrus Energy has completed and shipped the first new centrifuge from its Oak Ridge, Tennessee, manufacturing plant to support a multi-billion-dollar expansion of its uranium enrichment capacity in Ohio. This milestone marks the transition to high-rate manufacturing and the establishment of a complete, unobligated domestic supply chain for both commercial and national security markets.

8:25 AM ET 8-K
M&A Deal DoorDash, Inc. DASH

DoorDash Signs $17B M&A Deal with Maplebear Inc.

DoorDash has entered into a definitive agreement to acquire Instacart for $65.00 per share, representing an equity value of approximately $17 billion. The consideration will be at least 75% cash, with Instacart stockholders able to elect cash, DoorDash stock, or a combination of both, subject to a 25% cap on the total stock component.

Value
$17B
Counterparty
Maplebear Inc. (d.b.a. Instacart)

“Grocery is one of the hardest things to get right online. Someone has to pick a ripe avocado, find a substitute you’d choose yourself, and get the ice cream to you before it melts. Instacart has spent years learning to do that well for grocers, while DoorDash has built a delivery network and technology that local stores rely on every day. Together, we could give stores of every size more of those tools and unlock the potential of grocery delivery. It’s still early innings, but we know that when more people shop local, more dollars stay local.”

Tony Xu, co-founder and CEO of DoorDash

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.